Erin O'Shea

Erin O'Shea is an American systems biologist and academic leader renowned for her pioneering research in cellular signaling and gene regulation. She has held prominent leadership positions at premier research institutions, shaping the direction of modern biomedical science. Her work integrates biochemistry, genetics, and computational approaches to understand fundamental biological circuits.

Early life and education

O'Shea completed her undergraduate studies in chemistry at the University of Wisconsin–Madison, laying a strong foundation in the physical sciences. She then pursued her Ph.D. in chemistry at the Massachusetts Institute of Technology, where her doctoral research focused on mechanistic enzymology. Her postdoctoral fellowship was conducted at the University of California, San Francisco, marking a transition into eukaryotic signal transduction and molecular biology.

Academic career and research

O'Shea began her independent faculty career in the Department of Biochemistry and Biophysics at the University of California, San Francisco, establishing a laboratory focused on phosphorylation-based signaling networks. She later joined the faculty of Harvard University, where she was appointed as a Howard Hughes Medical Institute Investigator and a professor in the Department of Molecular and Cellular Biology. Her research group made seminal contributions to understanding the yeast phosphate response pathway, using it as a model to decipher general principles of gene regulation. A major line of her work also elucidated the molecular mechanisms of circadian clocks in cyanobacteria, revealing how protein oscillations can generate rhythmicity. This interdisciplinary research bridged structural biology, single-cell analysis, and quantitative modeling, establishing her as a leader in the field of systems biology.

Leadership roles

O'Shea returned to the University of California, San Francisco in a major administrative capacity, serving as the Vice President and Chief Scientific Officer for the Howard Hughes Medical Institute's Janelia Research Campus, guiding its scientific strategy. She subsequently became the President of the Howard Hughes Medical Institute, one of the largest private biomedical research organizations in the United States. In this role, she oversaw the institute's vast research portfolio, its network of HHMI Investigators at universities across the country, and science education initiatives. She has also served on numerous influential boards, including the Scientific Advisory Board for the Max Planck Institute and the President's Council of Advisors on Science and Technology.

Awards and honors

O'Shea's scientific contributions have been recognized with election to several prestigious academies, including the National Academy of Sciences and the American Academy of Arts and Sciences. She is also a fellow of the American Association for the Advancement of Science. Her research has been supported by major grants from the National Institutes of Health and she has received notable awards such as the Chugai Award for her work in molecular biology. She has delivered distinguished lectureships, including the Keith R. Porter Lecture, and served on the editorial boards of leading journals like Science and eLife.

Personal life

O'Shea maintains a private personal life while being an advocate for diversity and inclusion within the STEM fields. She is known as a dedicated mentor who has trained many scientists who have gone on to successful careers in academia and industry.

Category:American biologists Category:Systems biologists Category:Harvard University faculty Category:Howard Hughes Medical Institute